Annual report pursuant to Section 13 and 15(d)

Stock options, warrants and restricted common stock (Tables)

v3.19.1
Stock options, warrants and restricted common stock (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Recognized Stock-based Compensation
The Company recognized total stock-based compensation expense during the years ended December 31, 2018 and 2017, from the following categories:
 
   
Years Ended December 31,
 
   
2018
   
2017
 
Restricted stock awards under the Plan
 
$
3,971,916
   
$
1,714,116
 
Stock option awards under the Plan
   
688,490
     
875,696
 
    Total stock-based compensation
 
$
4,660,406
   
$
2,589,812
 
 
Summary of Restricted Stock Activity
A summary of the Company's restricted stock activity in the years ended December 31, 2018 and 2017 is as follows:

   
Number of Shares
   
Weighted Average Grant-Date
Fair Value
 
Unvested at January 1, 2017
   
-
   
$
-
 
Granted
   
863,000
   
$
5.39
 
Vested
   
(326,848
)
 
$
4.87
 
Forfeited
   
(40,000
)
 
$
3.13
 
Unvested at December 31, 2017
   
496,152
   
$
5.97
 
Granted
   
431,000
   
$
10.46
 
Vested
   
(530,065
)
 
$
7.61
 
Forfeited
   
(301,148
)
 
$
7.68
 
Unvested at December 31, 2018
   
95,939
   
$
12.49
 
Schedule of Fair Value Assumptions Used to Estimate Stock-based Compensation
The Company currently provides stock-based compensation to employees, directors and consultants under the Plan.  The Company utilized assumptions in the estimation of fair value of stock-based compensation for the years ended December 31, 2018 and 2017, as follows: 

 
Years Ended December 31,
 
2018
 
2017
Dividend yield
0%
 
0%
Expected price volatility
152% - 159%
 
15% - 95%
Risk free interest rate
2.49% - 2.96%
 
1.92-1.99%
Expected term
5 years
 
5 years
Summary of Stock Incentive Plan Activity
A summary of stock option activity under the Plan for options to employees, officers, directors and consultants, for the years ended December 31, 2018 and 2017, is presented below:
 
   
Shares Underlying Options
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual
Term (Years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2017
   
566,747
   
$
20.46
             
     Granted
   
120,000
   
$
9.00
             
     Exercised
   
(50,800
)
 
$
2.94
             
     Forfeited
   
(516,414
)
 
$
22.16
             
Outstanding at December 31, 2017
   
119,533
   
$
9.02
     
9.8
   
$
2,316,000
 
     Granted
   
62,000
   
$
15.71
                 
     Exercised
   
(19,533
)
 
$
4.02
                 
     Forfeited
   
(100,000
)
 
$
10.00
                 
Outstanding at December 31, 2018
   
62,000
   
$
15.71
     
9.2
   
$
-
 
                                 
Exercisable at December 31, 2018
   
57,836
   
$
15.51
     
9.2
   
$
-
 
Schedule of Changes in Outstanding Warrants
The following is a summary of the change in outstanding warrants during the years ended December 31, 2018 and 2017:
 
   
Shares Underlying Options/Warrants
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual
Term (Years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2017
   
527,003
   
$
13.36
             
Granted
   
4,451,113
   
$
17.03
             
Exercised for cash
   
(620,000
)
 
$
3.00
             
Exercised on a cashless basis
   
(2,244,147
)
 
$
-
             
Forfeited
   
(169,074
)
 
$
18.62
             
Outstanding at December 31, 2017
   
1,944,895
   
$
35.06
     
2.7
   
$
6,135,000
 
Granted
   
-
   
$
-
                 
Exercised
   
(113,009
)
 
$
3.50
                 
Forfeited
   
(160,773
)
 
$
10.88
                 
Outstanding at December 31, 2018
   
1,671,113
   
$
39.47
     
2.0
   
$
-
 
                                 
Exercisable at December 31, 2018
   
1,671,113
   
$
39.47
     
2.0
   
$